Pharma Journalist -

Alnylam Pharmaceuticals, Inc. announced positive topline results from the ILLUMINATE-B pediatric Phase 3 study of lumasiran, an investigational RNAi therapeutic targeting hydroxyacid…
Read More...

Covis Group S.à r.l. and AMAG Pharmaceuticals, Inc. announced that they have entered into a definitive agreement under which Covis will acquire AMAG for $13.75 per share in cash, or…
Read More...

ViralClear Pharmaceuticals, Inc. and Sorrento Therapeutics, Inc. announced the companies are exploring the synergistic potential of small molecules and antibodies combination therapies…
Read More...

Eisai Co., Ltd. and Seikagaku Corporation announced that the companies have entered into an agreement for the marketing alliance in South Korea for SI-613 (diclofenac conjugated sodium…
Read More...

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female oncology products in the precision medicine metastatic breast cancer…
Read More...

Kuur Therapeutics, a leader in the development of off-the-shelf CAR-NKT cell immunotherapies for the treatment of hematological and solid malignancies, today announced the treatment of…
Read More...

CStone Pharmaceuticals and Pfizer Investment Co. Ltd. and Pfizer Corporation Hong Kong Limited announced today the formation of a strategic collaboration that encompasses a $200 million…
Read More...

Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and Arbor Biotechnologies, an early-stage life sciences company,…
Read More...

Orgenesis Inc. and Koligo Therapeutics, Inc. announced that the two companies have entered into a definitive merger agreement, subject to final closing conditions, with expected…
Read More...

FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs, is pleased to announce it has entered into a manufacturing agreement with…
Read More...